S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
Bank Collapse Causes Gold Prices to Soar (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Famous Wall Street Crash System Flashes RED (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
Famous Wall Street Crash System Flashes RED (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
Bank Collapse Causes Gold Prices to Soar (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Famous Wall Street Crash System Flashes RED (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
Famous Wall Street Crash System Flashes RED (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
Bank Collapse Causes Gold Prices to Soar (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Famous Wall Street Crash System Flashes RED (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
Famous Wall Street Crash System Flashes RED (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
Bank Collapse Causes Gold Prices to Soar (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Famous Wall Street Crash System Flashes RED (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
Famous Wall Street Crash System Flashes RED (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
NASDAQ:TXMD

TherapeuticsMD (TXMD) Stock Forecast, Price & News

$4.36
-0.04 (-0.91%)
(As of 06/5/2023 ET)
Compare
Today's Range
$4.30
$4.49
50-Day Range
$3.42
$4.49
52-Week Range
$3.25
$11.69
Volume
13,423 shs
Average Volume
39,907 shs
Market Capitalization
$44.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

TXMD stock logo

About TherapeuticsMD (NASDAQ:TXMD) Stock

TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.

Receive TXMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter.

TXMD Stock News Headlines

“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
TherapeuticsMD (NASDAQ:TXMD) Shares Down 5.4%
Master Market Movements: Free Stock Analysis Report with Predictive Buy/Sell/Hold Insights!
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
(NYSE:SNY) vs. (NYSE:TXMD) Financial Survey
TherapeuticsMD (NYSE:TXMD) & Sanofi (NYSE:SNY) Financial Review
Reviewing Sanofi (NYSE:SNY) & TherapeuticsMD (NYSE:TXMD)
TheraputicsMD sells products rights for $153 million
See More Headlines

TXMD Price History

TXMD Company Calendar

Last Earnings
5/15/2023
Today
6/05/2023
Next Earnings (Estimated)
8/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TXMD
Previous Symbol
NYSEMKT:TXMD
Employees
416
Year Founded
N/A

Profitability

Net Income
$112 million
Pretax Margin
23.88%

Debt

Sales & Book Value

Annual Sales
$69.96 million
Book Value
$3.73 per share

Miscellaneous

Free Float
10,013,000
Market Cap
$44.21 million
Optionable
Optionable
Beta
1.16

Key Executives

  • Marlan WalkerMarlan Walker
    Chief Executive Officer
  • Michael Donegan
    Chief Financial & Accounting Officer
  • Douglas Mike Steelman
    Vice President-Market Access
  • Bharat Warrier
    Chief Manufacturing Officer
  • Kristen Landon
    VP-Marketing & Head-Media













TXMD Stock - Frequently Asked Questions

Should I buy or sell TherapeuticsMD stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TherapeuticsMD in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TXMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TXMD, but not buy additional shares or sell existing shares.
View TXMD analyst ratings
or view top-rated stocks.

How have TXMD shares performed in 2023?

TherapeuticsMD's stock was trading at $5.59 at the start of the year. Since then, TXMD shares have decreased by 22.0% and is now trading at $4.36.
View the best growth stocks for 2023 here
.

When is TherapeuticsMD's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023.
View our TXMD earnings forecast
.

How were TherapeuticsMD's earnings last quarter?

TherapeuticsMD, Inc. (NASDAQ:TXMD) announced its quarterly earnings data on Monday, May, 15th. The company reported ($0.24) EPS for the quarter. The business had revenue of $0.42 million for the quarter.

When did TherapeuticsMD's stock split?

Shares of TherapeuticsMD reverse split on the morning of Monday, May 9th 2022. The 1-50 reverse split was announced on Monday, May 9th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of TherapeuticsMD own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TherapeuticsMD investors own include OPKO Health (OPK), Verastem (VSTM), Teva Pharmaceutical Industries (TEVA), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Gilead Sciences (GILD), Cleveland-Cliffs (CLF), Novavax (NVAX) and Micron Technology (MU).

What is TherapeuticsMD's stock symbol?

TherapeuticsMD trades on the NASDAQ under the ticker symbol "TXMD."

Who are TherapeuticsMD's major shareholders?

TherapeuticsMD's stock is owned by many different institutional and retail investors. Top institutional shareholders include Rubric Capital Management LP (11.76%), Tejara Capital Ltd (3.51%), Geode Capital Management LLC (0.81%), Group One Trading L.P. (0.00%), Charles Schwab Investment Management Inc. (0.52%) and Sanders Morris Harris LLC (0.36%). Insiders that own company stock include Brian Bernick, Cooper C Collins, Edward Borkowski, Gail K Naughton, James Darecca, Marlan D Walker, Marlan D Walker, Michael C Donegan, Michael C Donegan, Paul Bisaro, Robert G Finizio, Rubric Capital Management Lp, Tommy G Thompson and Tommy G Thompson.
View institutional ownership trends
.

How do I buy shares of TherapeuticsMD?

Shares of TXMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TherapeuticsMD's stock price today?

One share of TXMD stock can currently be purchased for approximately $4.36.

How much money does TherapeuticsMD make?

TherapeuticsMD (NASDAQ:TXMD) has a market capitalization of $44.21 million and generates $69.96 million in revenue each year.

How many employees does TherapeuticsMD have?

The company employs 416 workers across the globe.

How can I contact TherapeuticsMD?

TherapeuticsMD's mailing address is 951 Yamato Road Suite 220, BOCA RATON FL, 33431. The official website for the company is www.therapeuticsmd.com. The company can be reached via phone at (561) 961-1900, via email at shareholder@broadridge.com, or via fax at 561-431-3389.

This page (NASDAQ:TXMD) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -